Huntington National Bank’s Exact Sciences EXAS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $1.9K | Sell |
1
-28
| -97% | -$2.88K | ﹤0.01% | 2292 |
|
|
2025
Q4 | $2.94K | Sell |
29
-155
| -84% | -$12.4K | ﹤0.01% | 2120 |
|
|
2025
Q3 | $10.1K | Buy |
184
+160
| +667% | +$7.99K | ﹤0.01% | 1811 |
|
|
2025
Q2 | $1.27K | Buy |
24
+17
| +243% | +$864 | ﹤0.01% | 2300 |
|
|
2025
Q1 | $303 | Sell |
7
-63
| -90% | -$3.19K | ﹤0.01% | 2550 |
|
|
2024
Q4 | $3.93K | Sell |
70
-324
| -82% | -$20.2K | ﹤0.01% | 2075 |
|
|
2024
Q3 | $26.8K | Buy |
394
+352
| +838% | +$19.9K | ﹤0.01% | 1414 |
|
|
2024
Q2 | $1.77K | Sell |
42
-29
| -41% | -$1.6K | ﹤0.01% | 2188 |
|
|
2024
Q1 | $4.9K | Sell |
71
-5
| -7% | -$316 | ﹤0.01% | 1933 |
|
|
2023
Q4 | $5.62K | Sell |
76
-26
| -25% | -$1.7K | ﹤0.01% | 1855 |
|
|
2023
Q3 | $6.96K | Buy |
102
+5
| +5% | +$424 | ﹤0.01% | 1700 |
|
|
2023
Q2 | $9.11K | Buy |
97
+46
| +90% | +$3.59K | ﹤0.01% | 1598 |
|
|
2023
Q1 | $3.46K | Buy |
+51
| New | +$3.28K | ﹤0.01% | 1830 |
|
|
2022
Q3 | – | Sell |
-125
| Closed | -$5K | – | 2118 |
|
|
2022
Q2 | $5K | Hold |
125
| – | – | ﹤0.01% | 1721 |
|
|
2022
Q1 | $9K | Hold |
125
| – | – | ﹤0.01% | 1629 |
|
|
2021
Q4 | $10K | Sell |
125
-17
| -12% | -$1.5K | ﹤0.01% | 1573 |
|
|
2021
Q3 | $14K | Hold |
142
| – | – | ﹤0.01% | 1357 |
|
|
2021
Q2 | $18K | Hold |
142
| – | – | ﹤0.01% | 1282 |
|
|
2021
Q1 | $19K | Hold |
142
| – | – | ﹤0.01% | 1150 |
|
|
2020
Q4 | $19K | Buy |
+142
| New | +$17.2K | ﹤0.01% | 1138 |
|
|
2020
Q3 | – | Sell |
-13
| Closed | -$1K | – | 1569 |
|
|
2020
Q2 | $1K | Buy |
+13
| New | +$1.04K | ﹤0.01% | 1460 |
|
|
2020
Q1 | – | Sell |
-230
| Closed | -$21K | – | 1612 |
|
|
2019
Q4 | $21K | Buy |
+230
| New | +$20.2K | ﹤0.01% | 1233 |
|
|
2019
Q1 | – | Sell |
-13
| Closed | – | – | 1614 |
|
|
2018
Q4 | $0 | Hold |
13
| – | – | ﹤0.01% | 1704 |
|
|
2018
Q3 | $1K | Buy |
+13
| New | +$848 | ﹤0.01% | 1625 |
|
|
2018
Q1 | – | Sell |
-1,023
| Closed | -$54K | – | 1596 |
|
|
2017
Q4 | $54K | Hold |
1,023
| – | – | ﹤0.01% | 954 |
|
|
2017
Q3 | $48K | Sell |
1,023
-648
| -39% | -$26.1K | ﹤0.01% | 995 |
|
|
2017
Q2 | $59K | Sell |
1,671
-1,061
| -39% | -$32.7K | ﹤0.01% | 904 |
|
|
2017
Q1 | $65K | Buy |
2,732
+818
| +43% | +$16.2K | ﹤0.01% | 857 |
|
|
2016
Q4 | $26K | Buy |
1,914
+1,297
| +210% | +$20.9K | ﹤0.01% | 1063 |
|
|
2016
Q3 | $11K | Buy |
+617
| New | +$10.9K | ﹤0.01% | 1236 |
|
Other funds holding EXAS
PRS
PWMAG
IA
BC
Huntington National Bank's EXAS Position: Q1 2026 in Review
Huntington National Bank reduced its Exact Sciences (EXAS) stake by 97% in Q1 2026, selling an estimated $2.88K and leaving 1 share worth $1.9K. The position accounts for ﹤0.01% of the portfolio, ranked #2292.
Huntington National Bank first reported a position in EXAS in Q3 2016 and has held it in 30 quarters since. The position peaked at $65K in Q1 2017. 7 funds tracked by Wall St. Rank hold EXAS as of Q1 2026.
- Huntington National Bank held 1 share of Exact Sciences worth $1.9K as of Q1 2026.
- Huntington National Bank sold 28 Exact Sciences shares in Q1 2026, an estimated $2.88K.
- Exact Sciences made up ﹤0.01% of Huntington National Bank's portfolio in Q1 2026, its #2292 holding.
- Huntington National Bank first reported a position in Exact Sciences in Q3 2016 and has held it in 30 quarters since.
- Huntington National Bank's Exact Sciences position peaked at $65K in Q1 2017.
- 7 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2026.
Based on Huntington National Bank's 13F filing for Q1 2026, filed 15 May 2026.